Tomas T. Ding

3.4k total citations · 2 hit papers
13 papers, 2.9k citations indexed

About

Tomas T. Ding is a scholar working on Neurology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Tomas T. Ding has authored 13 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Neurology, 4 papers in Molecular Biology and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Tomas T. Ding's work include Parkinson's Disease Mechanisms and Treatments (6 papers), Neurological disorders and treatments (4 papers) and Alzheimer's disease research and treatments (3 papers). Tomas T. Ding is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (6 papers), Neurological disorders and treatments (4 papers) and Alzheimer's disease research and treatments (3 papers). Tomas T. Ding collaborates with scholars based in United States, China and Australia. Tomas T. Ding's co-authors include Peter T. Lansbury, Jean‐Christophe Rochet, Seung‐Jae Lee, Kelly A. Conway, Robin E. Williamson, Mark D. Shtilerman, Michael J. Volles, James D. Harper, Tiago F. Outeiro and Robert M. Bieganski and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Biochemistry and Annals of the New York Academy of Sciences.

In The Last Decade

Tomas T. Ding

13 papers receiving 2.8k citations

Hit Papers

Acceleration of oligomerization, not fibrillization, is a... 2000 2026 2008 2017 2000 2001 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomas T. Ding United States 10 1.9k 1.4k 994 820 409 13 2.9k
Wendy S. Woods United States 21 1.6k 0.9× 985 0.7× 1.0k 1.0× 700 0.9× 232 0.6× 32 2.7k
Marçal Vilar Spain 24 1.2k 0.7× 1.0k 0.8× 1.2k 1.2× 783 1.0× 280 0.7× 46 3.0k
Karine Madiona France 17 1.3k 0.7× 909 0.7× 774 0.8× 544 0.7× 379 0.9× 20 2.3k
Tim Bartels United States 19 2.4k 1.3× 1.5k 1.1× 1.2k 1.2× 1.0k 1.2× 608 1.5× 30 3.6k
Silvia Campioni Switzerland 20 1.3k 0.7× 1.7k 1.2× 1.6k 1.6× 522 0.6× 282 0.7× 32 3.3k
Michael J. Volles United States 9 1.3k 0.7× 887 0.7× 660 0.7× 555 0.7× 230 0.6× 9 1.9k
Abid Oueslati Canada 21 2.6k 1.4× 1.3k 0.9× 1.1k 1.1× 1.3k 1.6× 506 1.2× 39 3.6k
Adrien W. Schmid Switzerland 18 815 0.4× 820 0.6× 835 0.8× 430 0.5× 267 0.7× 26 2.0k
Giuliana Fusco United Kingdom 19 1.3k 0.7× 1.1k 0.8× 852 0.9× 420 0.5× 156 0.4× 36 2.2k
Céline Galvagnion United Kingdom 21 1.5k 0.8× 1.7k 1.3× 1.5k 1.5× 345 0.4× 187 0.5× 28 3.2k

Countries citing papers authored by Tomas T. Ding

Since Specialization
Citations

This map shows the geographic impact of Tomas T. Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomas T. Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomas T. Ding more than expected).

Fields of papers citing papers by Tomas T. Ding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomas T. Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomas T. Ding. The network helps show where Tomas T. Ding may publish in the future.

Co-authorship network of co-authors of Tomas T. Ding

This figure shows the co-authorship network connecting the top 25 collaborators of Tomas T. Ding. A scholar is included among the top collaborators of Tomas T. Ding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomas T. Ding. Tomas T. Ding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Hung, Chiu‐Yueh, Chuanshu Zhu, Farooqahmed S. Kittur, et al.. (2022). A plant-based mutant huntingtin model-driven discovery of impaired expression of GTPCH and DHFR. Cellular and Molecular Life Sciences. 79(11). 553–553. 4 indexed citations
2.
Guo, Yongzhen, Jingwen Zhang, Jing Li, et al.. (2021). Damage to the blood‑brain barrier and activation of neuroinflammation by focal cerebral ischemia under hyperglycemic condition. International Journal of Molecular Medicine. 48(1). 25 indexed citations
3.
Ding, Tomas T., et al.. (2015). PENGARUH BERAT BENIH DAN MEDIA TANAM TERHADAP PERTUMBUHAN VEGETATIF BIBIT DURIAN (Durio Zibethinus Murr). 14(2). 261–268. 2 indexed citations
4.
Vinodgopal, K., Bernaurdshaw Neppolian, Ian V. Lightcap, et al.. (2012). Dual-frequency ultrasound for designing two dimensional catalyst surface: Reduced graphene oxide–Pt composite. Colloids and Surfaces A Physicochemical and Engineering Aspects. 409. 81–87. 26 indexed citations
5.
Shim, Joong‐Youn, et al.. (2010). Distinct second extracellular loop structures of the brain cannabinoid CB1 receptor: Implication in ligand binding and receptor function. Proteins Structure Function and Bioinformatics. 79(2). 581–597. 3 indexed citations
6.
Zhang, Haiqiang, et al.. (2009). Therapeutic effects of Clostridium butyricum on experimental colitis induced by oxazolone in rats. World Journal of Gastroenterology. 15(15). 1821–1821. 47 indexed citations
7.
Rochet, Jean‐Christophe, Tiago F. Outeiro, Kelly A. Conway, et al.. (2004). Interactions Among α-Synuclein, Dopamine, and Biomembranes: Some Clues for Understanding Neurodegeneration in Parkinson's Disease. Journal of Molecular Neuroscience. 23(1-2). 23–34. 149 indexed citations
8.
Ding, Tomas T., Seung‐Jae Lee, Jean‐Christophe Rochet, & Peter T. Lansbury. (2002). Annular α-Synuclein Protofibrils Are Produced When Spherical Protofibrils Are Incubated in Solution or Bound to Brain-Derived Membranes. Biochemistry. 41(32). 10209–10217. 304 indexed citations
9.
Shtilerman, Mark D., Tomas T. Ding, & Peter T. Lansbury. (2002). Molecular Crowding Accelerates Fibrillization of α-Synuclein:  Could an Increase in the Cytoplasmic Protein Concentration Induce Parkinson's Disease?. Biochemistry. 41(12). 3855–3860. 237 indexed citations
10.
Volles, Michael J., Seung‐Jae Lee, Jean‐Christophe Rochet, et al.. (2001). Vesicle Permeabilization by Protofibrillar α-Synuclein:  Implications for the Pathogenesis and Treatment of Parkinson's Disease. Biochemistry. 40(26). 7812–7819. 581 indexed citations breakdown →
11.
Conway, Kelly A., Jean‐Christophe Rochet, Tomas T. Ding, et al.. (2000). Accelerated Oligomerization by Parkinson's Disease Linked α‐Synuclein Mutants. Annals of the New York Academy of Sciences. 920(1). 42–45. 179 indexed citations
12.
Conway, Kelly A., Seung‐Jae Lee, Jean‐Christophe Rochet, et al.. (2000). Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease: Implications for pathogenesis and therapy. Proceedings of the National Academy of Sciences. 97(2). 571–576. 1269 indexed citations breakdown →
13.
Ding, Tomas T. & James D. Harper. (1999). [33] Analysis of amyloid-β assemblies using tapping mode atomic force microscopy under ambient conditions. Methods in enzymology on CD-ROM/Methods in enzymology. 309. 510–525. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026